92 related articles for article (PubMed ID: 12771645)
21. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
22. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
[TBL] [Abstract][Full Text] [Related]
23. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
24. I have been diagnosed with a poor ejection fraction from my left ventricle. What does that mean, and what medications would be most beneficial?
Health News; 2006 Feb; 12(2):16. PubMed ID: 16453941
[No Abstract] [Full Text] [Related]
25. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
[TBL] [Abstract][Full Text] [Related]
26. [ACE inhibitors in the treatment of ventricular dysfunction caused by cardiotoxic cytostatics].
Mladosievicová B
Ceska Slov Farm; 2004 Mar; 53(2):55-60. PubMed ID: 15095572
[TBL] [Abstract][Full Text] [Related]
27. All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors.
Lazar HL
Circulation; 2008 Jan; 117(1):6-8. PubMed ID: 18172046
[No Abstract] [Full Text] [Related]
28. Valsartan, captopril, or both in myocardial infarction.
McAnulty JH
N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14985495
[No Abstract] [Full Text] [Related]
29. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
Völzke H; Kleine V; Robinson DM; Grimm R; Hertwig S; Schwahn C; Eckel L; Rettig R
Int J Cardiol; 2005 Jan; 98(1):133-9. PubMed ID: 15676177
[TBL] [Abstract][Full Text] [Related]
30. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT;
Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
[TBL] [Abstract][Full Text] [Related]
31. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
[TBL] [Abstract][Full Text] [Related]
32. [Left ventricular hypertrophy--its reversion speeded up by enalaprilat].
Póvoa R; Luna Filho B; Ferreira C; Antonangelo L; Capellozzi V; Murad N
Rev Port Cardiol; 1997 Jan; 16(1):57-60. PubMed ID: 9115778
[No Abstract] [Full Text] [Related]
33. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta.
Rouine-Rapp K; Mello DM; Hanley FL; Mohan Reddy V; Soifer S
Pediatr Crit Care Med; 2003 Jul; 4(3):327-32. PubMed ID: 12831415
[TBL] [Abstract][Full Text] [Related]
34. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
[TBL] [Abstract][Full Text] [Related]
35. Invited commentary.
Thomas SP
Ann Thorac Surg; 2009 Sep; 88(3):807-8. PubMed ID: 19699902
[No Abstract] [Full Text] [Related]
36. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.
Koch M; Bonaventura K; Spillmann F; Dendorfer A; Schultheiss HP; Tschöpe C
Biol Chem; 2008 Jun; 389(6):719-23. PubMed ID: 18627293
[TBL] [Abstract][Full Text] [Related]
37. Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress?
Schaefer U; Kurz T; Bonnemeier H; Dendorfer A; Hartmann F; Schunkert H; Richardt G
J Intern Med; 2007 Feb; 261(2):188-200. PubMed ID: 17241184
[TBL] [Abstract][Full Text] [Related]
38. Survival after isolated coronary artery bypass grafting in patients with severe left ventricular dysfunction.
Ahmed WA; Tully PJ; Baker RA; Knight JL
Ann Thorac Surg; 2009 Apr; 87(4):1106-12. PubMed ID: 19324135
[TBL] [Abstract][Full Text] [Related]
39. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
Kjøller-Hansen L; Steffensen R; Grande P
Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
[TBL] [Abstract][Full Text] [Related]
40. Medication performance measures and mortality following acute coronary syndromes.
Granger CB; Steg PG; Peterson E; López-Sendón J; Van de Werf F; Kline-Rogers E; Allegrone J; Dabbous OH; Klein W; Fox KA; Eagle KA;
Am J Med; 2005 Aug; 118(8):858-65. PubMed ID: 16084178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
